NCT00413751View on ClinicalTrials.gov

Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions
Healthy
Interventions
DRUG

Brimonidine tartrate ophthalmic solution 0.15% (Alphagan P)

Trial Locations (1)

20307

Walter Reed Army Medical Center, Washington D.C.

All Listed Sponsors
lead

Walter Reed Army Medical Center

FED

NCT00413751 - Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes | Biotech Hunter | Biotech Hunter